Average Co-Inventor Count = 1.95
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Envirologix Inc. (15 from 16 patents)
2. Shaffer, Daniel (0 patent)
3. Judice, Stephen A. (0 patent)
15 patents:
1. 12392001 - Compositions and methods for detecting an RNA virus
2. 12258637 - Compositions and methods for enhancing and/or predicting DNA amplification
3. 12043866 - Compositions and methods for quantifying a nucleic acid sequence in a sample
4. 11866773 - Isolated oligonucleotides containing modified nucleotides
5. 11505836 - Compositions and methods for enhancing and/or predicting DNA amplification
6. 11220708 - Compositions and methods for detecting nicking enzyme and polymerase activity using a substrate molecule
7. 11208687 - Compositions and methods for quantifying a nucleic acid sequence in a sample
8. 10793922 - Compositions and methods for detecting an RNA virus
9. 10584376 - Compositions and methods for detecting a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3'-terminal region comprising a 2′-modified nucleotide
10. 10570441 - Compositions and methods for detecting nicking enzyme and polymerase activity using a substrate molecule
11. 10077467 - Compositions and methods for detecting a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3'-terminal region comprising a 2′-modified nucleotide
12. 9845510 - [object Object]
13. 9631231 - Compositions and methods for amplifying a nucleic acid sequence comprising a primer oligonucleotide with a 3'-terminal region comprising a 2′-modified nucleotide
14. 9322053 - Compositions and methods for monitoring in real time a nicking amplification reaction comprising a primer oligonucleotide with a 3'—terminal region comprising A2′—modified nucleotide
15. 9096897 - Compositions and methods for quantifying a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3'-terminal region comprising a 2′-modified nucleotide